24 May 2013
Keywords: uses, merck, proscar, phase, ii, study, co
Article | 18 May 1992
A Phase II study of Merck & Co's 5-alpha reductase inhibitor Proscar
(finasteride) as an adjuvant treatment following radical prostatectomy
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 May 1992
23 May 2013
© 2013 thepharmaletter.com